- Home
- XRTX vs RSLS Comparison
XRTX vs RSLS Comparison
Compare XRTX & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- RSLS
- Stock Information
- Founded
- XRTX 2011
- RSLS 2002
- Country
- XRTX Canada
- RSLS United States
- Employees
- XRTX N/A
- RSLS N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- RSLS Medical/Dental Instruments
- Sector
- XRTX Health Care
- RSLS Health Care
- Exchange
- XRTX Nasdaq
- RSLS Nasdaq
- Market Cap
- XRTX 3.0M
- RSLS 3.2M
- IPO Year
- XRTX N/A
- RSLS 2007
- Fundamental
- Price
- XRTX $0.92
- RSLS $0.65
- Analyst Decision
- XRTX
- RSLS Hold
- Analyst Count
- XRTX 0
- RSLS 1
- Target Price
- XRTX N/A
- RSLS N/A
- AVG Volume (30 Days)
- XRTX 84.2K
- RSLS 3.3M
- Earning Date
- XRTX 05-09-2025
- RSLS 03-31-2025
- Dividend Yield
- XRTX N/A
- RSLS N/A
- EPS Growth
- XRTX N/A
- RSLS N/A
- EPS
- XRTX N/A
- RSLS N/A
- Revenue
- XRTX N/A
- RSLS $8,183,000.00
- Revenue This Year
- XRTX N/A
- RSLS $17.47
- Revenue Next Year
- XRTX N/A
- RSLS $20.00
- P/E Ratio
- XRTX N/A
- RSLS N/A
- Revenue Growth
- XRTX N/A
- RSLS N/A
- 52 Week Low
- XRTX $0.82
- RSLS $0.63
- 52 Week High
- XRTX $5.81
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- XRTX 42.89
- RSLS 20.22
- Support Level
- XRTX $0.85
- RSLS $0.88
- Resistance Level
- XRTX $1.10
- RSLS $1.28
- Average True Range (ATR)
- XRTX 0.11
- RSLS 0.17
- MACD
- XRTX 0.00
- RSLS 0.05
- Stochastic Oscillator
- XRTX 11.63
- RSLS 7.95
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.